Picture of Abiomed logo

ABMD Abiomed Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Annual cashflow statement for Abiomed, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2018
March 31st
2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line112259203226137
Depreciation
Deferred Taxes
Non-Cash Items45.725.650.513149
Unusual Items
Other Non-Cash Items
Changes in Working Capital-18.9-38.88.03-17.4-30.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities193252315275285
Capital Expenditures-55.9-44-44-53.4-35.8
Purchase of Fixed Assets
Other Investing Cash Flow Items-125-72.5-81.4-170-345
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-181-116-125-223-381
Financing Cash Flow Items-20.3-71.8-41.7-11.3-18.9
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-9.14-55.8-118-8.07-2.2
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.947871.340.4-99.9

Or unlock with your email

Or unlock with your email